References

russjcardiol

Российский кардиологический журнал

Russian Journal of Cardiology

1560-40712618-7620

«SILICEA-POLIGRAF» LLC

10.15829/1560-4071-2022-5233

russjcardiol-5233

Research Article

КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ

CLINICAL GUIDELINES

Инфекционный эндокардит и инфекция внутрисердечных устройств. Клинические рекомендации 2021

Infectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021

Демин

А. А.

Demin

A. A.

Профессор, доктор медицинских наук

Новосибирск

Novosibirsk

Кобалава

Ж. Д.

Kobalava

Zh. D.

Член-корреспондент РАН, профессор, доктор медицинских наук

Москва

Moscow

Скопин

И. И.

Skopin

I. I.

Профессор, доктор медицинских наук

Москва

Moscow

Тюрин

В. П.

Tyurin

P. V.

Профессор, доктор медицинских наук

Москва

Moscow

Бойцов

С. А.

Boytsov

S. A.

Академик РАН, профессор, доктор медицинских наук

Москва

Moscow

Голухова

Е. З.

Golukhova

E. Z.

Академик РАН, профессор, доктор медицинских наук

Москва

Moscow

Гордеев

М. Л.

Gordeev

M. L.

Профессор, доктор медицинских наук

Санкт-Петербург

St. Petersburg

Гудымович

В. Г.

Gudymovich

V. D.

Доцент, доктор медицинских наук

Москва

Moscow

Демченко

Е. А.

Demchenko

E. A.

Доктор медицинских наук

Санкт-Петербург

St. Petersburg

Дробышева

В. П.

Drobysheva

V. P.

Профессор, доктор медицинских наук

Новосибирск

Novosibirsk

Домонова

Э. А.

Domonova

E. A.

Кандидат биологических наук

Москва

Moscow

Драпкина

О. М.

Drapkina

O. M.

Академик РАН, профессор, доктор медицинских наук

Москва

Moscow

Загородникова

К. А.

Zagorodnikova

K. A.

Кандидат медицинских наук

Санкт-Петербург

St. Petersburg

Иртюга

О. Б.

Irtyuga

O. B.

Кандидат медицинских наук

Санкт-Петербург

St. Petersburg

Кахкцян

П. В.

Kakhktsyan

P. S.

Кандидат медицинских наук

Москва

Moscow

Козлов

Р. С.

Kozlov

R. S.

Член-корреспондент РАН, профессор, доктор медицинских наук

Смоленск

Smolensk

Котова

Е. О.

Kotova

E. O.

Кандидат медицинских наук

Москва

Moscow

kotova_eo@pfur.ru

Медведев

А. П.

Medvedev

A. P.

Профессор, доктор медицинских наук

Нижний Новгород

Nizhny Novgorod

Муратов

Р. М.

Muratov

R. M.

Профессор, доктор медицинских наук

Москва

Moscow

Николаевский

Е. Н.

Nikolaevsky

E. N.

Профессор, доктор медицинских наук

Самара

Samara

Писарюк

А. С.

Pisaryuk

A. S.

Кандидат медицинских наук

Москва

Moscow

Пономарева

Е. Ю.

Ponomareva

E. Yu.

Кандидат медицинских наук

Москва

Saratov

Попов

Д. А.

Popov

D. A.

Профессор, доктор медицинских наук

Москва

Moscow

Рачина

С. А.

Rakhina

S. A.

Профессор, доктор медицинских наук

Москва

Moscow

Ревишвили

А. Ш.

Revishvili

A. G.

Академик РАН, профессор, доктор медицинских наук

Москва

Moscow

Резник

И. И.

Reznik

I. I.

Профессор, доктор медицинских наук

Екатеринбург

Yekaterinburg

Рыжкова

Д. В.

Ryzhkova

D. S.

Профессор, доктор медицинских наук

Санкт-Петербург

St. Petersburg

Сафарова

А. Ф.

Safarova

A. F.

Профессор, доктор медицинских наук

Москва

Moscow

Тазина

С. Я.

Tazina

S. Ya.

Доцент, доктор медицинских наук

Москва

Moscow

Чипигина

Н. С.

Chipigina

N. S.

Кандидат медицинских наук

Москва

Moscow

Шипулина

О. Ю.

Shipulina

O. Yu.

Кандидат медицинских наук

Москва

Moscow

Шляхто

Е. В.

Shlyakhto

E. S.

Академик РАН, профессор

Санкт-Петербург

Saint Petersburg

Шнейдер

Ю. А.

Schneider

Yu. A.

Профессор, доктор медицинских наук

Калининград

Kaliningrad

Шостак

Н. А.

Shostak

N. A.

Профессор, доктор медицинских наук

Москва

Moscow

Российское научное медицинское общество терапевтов; Российское кардиологическое обществоРоссияRussian Scientific Medical Society of Therapists; Russian Society of Cardiology;Russian Federation

Ассоциация сердечно-сосудистых хирургов РоссииRussian FederationAssociation of Cardiovascular Surgeons of RussiaRussian Federation

Российское научное медицинское общество терапевтовRussian FederationRussian Scientific Medical Society of TherapistsRussian Federation

Российское кардиологическое обществоRussian FederationRussian Society of CardiologyRussian Federation

Российское кардиологическое общество; Ассоциация сердечно-сосудистых хирургов РоссииRussian FederationRussian Society of Cardiology; Association of Cardiovascular Surgeons of RussiaRussian Federation

Всероссийское научно-практическое общество эпидемиологов, микробиологов и паразитологовRussian FederationAll-Russian Scientific and Practical Society of Epidemiologists, Microbiologists and ParasitologistsRussian Federation

Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапииRussian FederationInterregional Association for Clinical Microbiology and Antimicrobial ChemotherapyRussian Federation

Российское кардиологическое общество; Российское научное медицинское общество терапевтовRussian FederationRussian Scientific Medical Society of TherapistsRussian Federation

Российское кардиологическое общество; Российское научное медицинское общество терапевтовRussian FederationRussian Society of Cardiology; Russian Scientific Medical Society of TherapistsRussian Federation

Российское кардиологическое общество; Всероссийское научное общество специалистов по клинической электрофизиологии, аритмологии и кардиостимуляцииRussian FederationRussian Society of Cardiology; All-Russian Scientific Society of Specialists in Clinical Electrophysiology, arrhythmology and pacingRussian Federation

Российское кардиологическое общество; Российское общество ядерной медициныRussian FederationRussian Society of Cardiology; Russian Society of Nuclear Medicine ФRussian Federation

2022

24092022

271052335233

Copyright © Демин А.А., Кобалава Ж.Д., Скопин И.И., Тюрин В.П., Бойцов С.А., Голухова Е.З., Гордеев М.Л., Гудымович В.Г., Демченко Е.А., Дробышева В.П., Домонова Э.А., Драпкина О.М., Загородникова К.А., Иртюга О.Б., Кахкцян П.В., Козлов Р.С., Котова Е.О., Медведев А.П., Муратов Р.М., Николаевский Е.Н., Писарюк А.С., Пономарева Е.Ю., Попов Д.А., Рачина С.А., Ревишвили А.Ш., Резник И.И., Рыжкова Д.В., Сафарова А.Ф., Тазина С.Я., Чипигина Н.С., Шипулина О.Ю., Шляхто Е.В., Шнейдер Ю.А., Шостак Н.А., 2022

2022

Демин А.А., Кобалава Ж.Д., Скопин И.И., Тюрин В.П., Бойцов С.А., Голухова Е.З., Гордеев М.Л., Гудымович В.Г., Демченко Е.А., Дробышева В.П., Домонова Э.А., Драпкина О.М., Загородникова К.А., Иртюга О.Б., Кахкцян П.В., Козлов Р.С., Котова Е.О., Медведев А.П., Муратов Р.М., Николаевский Е.Н., Писарюк А.С., Пономарева Е.Ю., Попов Д.А., Рачина С.А., Ревишвили А.Ш., Резник И.И., Рыжкова Д.В., Сафарова А.Ф., Тазина С.Я., Чипигина Н.С., Шипулина О.Ю., Шляхто Е.В., Шнейдер Ю.А., Шостак Н.А.

Demin A.A., Kobalava Z.D., Skopin I.I., Tyurin P.V., Boytsov S.A., Golukhova E.Z., Gordeev M.L., Gudymovich V.D., Demchenko E.A., Drobysheva V.P., Domonova E.A., Drapkina O.M., Zagorodnikova K.A., Irtyuga O.B., Kakhktsyan P.S., Kozlov R.S., Kotova E.O., Medvedev A.P., Muratov R.M., Nikolaevsky E.N., Pisaryuk A.S., Ponomareva E.Y., Popov D.A., Rakhina S.A., Revishvili A.G., Reznik I.I., Ryzhkova D.S., Safarova A.F., Tazina S.Y., Chipigina N.S., Shipulina O.Y., Shlyakhto E.S., Schneider Y.A., Shostak N.A.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://russjcardiol.elpub.ru/jour/article/view/5233

Инфекционный эндокардит и инфекция внутрисердечных устройств у взрослых. Клинические рекомендации Минздрава России

инфекционный эндокардитэтиологияпатогенезэпидемиологияклассификацияклиническая картинадиагностикакритерии Дюкамикробиологическое (культуральное) исследованиеэхокардиографическое исследованиекомпьютерная томографиямагнитно-резонансная томографияантибактериальная терапияхирургическое лечениепротез клапанавнутрисердечное устройствоврожденные пороки сердцареабилитацияпрофилактикакоманда эндокардитапрогнозEuroSCORE II

infectious endocarditisetiologypathogenesisepidemiologyclassificationclinical picturediagnosisDuke criteriamicrobiological (cultural) examinationechocardiographic examinationcomputed tomographymagnetic resonance imagingantibacterial therapysurgical treatmentvalve prosthesisintracardiac devicecongenital heart defectsrehabilitationpreventionendocarditis teamprognosisEuroSCORE II

References1

Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30:2369-413. doi:10.1093/eurheartj/ehp285.

Feinleib M. A Dictionary of Epidemiology, Fourth Edition — Edited by John M. Last, Robert A. Spasoff, and Susan S. Harris, American Journal of Epidemiology. 2001;154(1):93-4. doi:10.1093/aje/154.1.93-a.

Национальный стандарт Российской Федерации ГОСТ Р 52379−2005 "Надлежащая клиническая практика" M.: Стандартинформ, 2005 p.39.

National standard of the Russian Federation GOST R 52379−2005 "Good Clinical Practice (GCP)" M.: Standartinform, 2005 p. 39. (In Russ).

Habib G, Lancellotti P, Antunes M, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36:3075-128. doi:10.1093/eurheartj/ehv319.

Инфекционный эндокардит. В кн: Национальное руководство. 2-е издание. Москва: "ГЭОТАР-Медиа" , 2018:605-20. ISBN: 978-5-9704-4810-6.

Infective endocarditis.In. National clinical guidelines 2d ed. Moscow: GEOTAR-Media, 2018:605–620. (In Russ.) ISBN: 978-5-9704-4810-6.

Андреева НАУЧНЫЙ СОТРУДНИК, Реброва О.Ю., Зорин Н.А. и др. Системы оценки достоверности научных доказательств и убедительности рекомендаций: сравнительная характеристика и перспективы унификации. Медицинские Технологии Оценка и Выбор. 2012;4:10–24.

Andreeva NS, Rebrova OYu, Zorin NA, et al. Systems for Assessing the Reliability of Scientific Evidence and the Grades of Recommendations: Comparison and Prospects for Unification. Medicinskie Tekhnologii Ocenka i Vybor. 2012;4:10-24. (In Russ).

Иртюга О.Б., Чистякова В.И., Тенчурина А.О. и др. Частота выявления и клиническая значимость латентного инфекционного эндокардита у пациентов с аортальным стенозом. Российский кардиологический журнал. 2019;(11):10-15 doi:10.15829/1560-4071-2019-11-10-15.

Irtyuga OB, Chistyakova VI, Tenchurina AO, et al. Detection rate and clinical significance of latent infective endocarditis in patients with aortic stenosis. Russian Journal of Cardiology. 2019;(11):10-5. (In Russ.) doi:10.15829/1560-4071-2019-11-10-15.

Тюрин В.П. Инфекционные эндокардиты. Москва: "ГЭОТАР-Медиа". 2012, p.368. ISBN: 978-5-9704-2080-5

Tyurin VP. Infective endocarditis. Moscow: GEOTAR-Media: 2012, p.368. (In Russ.) ISBN: 978-5-9704-2080-5

Данилов А.И., Козлов Р.С., Козлов С.Н., Евсеев А.В. Практика проведения микробиологической диагностики инфекционного эндокардита в Российской Федерации. Вестник Смоленской Государственной Медицинской Академии. 2019;18:90-4.

Danilov AI, Kozlov RS, Kozlov SN, Evseev AV. Practice microbiological diagnosis of infective endocarditis in the russian federaion. Vestnik Smolenskoj Gosudarstvennoj Medicinskoj Akademii. 2019;18:90-4. (In Russ.).

Yew H Sen, Murdoch DR. Global Trends in Infective Endocarditis Epidemiology. Curr Infect Dis Rep. 2012;14:367-72. doi:10.1007/s11908-012-0265-5.

Habib G, Erba PA, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40:3222-32. doi:10.1093/eurheartj/ehz620.

Liesenborghs L, Meyers S, Vanassche T, Verhamme P. Coagulation: At the heart of infective endocarditis. J Thromb Haemost. 2020;18:995-1008. doi:10.1111/jth.14736.

Шевченко Ю.Л. Инфекционный эндокардит. Руководство по кардиологии в четырех томах. Том 4: Заболевания сердечно-сосудистой системы (II) Москва: Практика, 2014, p.976. ISBN: · 978-5-89816-131-6

Shevchenko YuL. Infective endocarditis. Cardiology guidelines in four volumes. Volume 4: Diseases of the cardiovascular system (II). Moscow: Praktika, 2014, p.976. (In Russ.) ISBN: · 978-5-89816-131-6

Ambrosioni J, Hernandez-Meneses M, Téllez A, et al. The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century. Curr Infect Dis Rep. 2017;19:21. doi:10.1007/s11908-017-0574-9.

Моисеев В.С., Кобалава Ж.Д., Писарюк А.С. и др. Инфекционный эндокардит: клиническая характеристика и исходы (7-летний опыт лечения и наблюдения в многопрофильной городской больнице). Кардиология. 2018;58(12):66-75 doi:10.18087/cardio.2018.12.10192.

Moiseev VS, Kobalava ZD, Pisaryuk AS, et al. Infective Endocarditis in Moscow General Hospital: Clinical Characteristics and Outcomes (Single-Center 7 Years’ Experience). Kardiologiia. 2018;58(12):66-75. (In Russ.) doi:10.18087/cardio.2018.12.10192.

Federal State Statistics Service (Rosstat). (In Russ.) Федеральная служба государственной статистики. Available from: https://rosstat.gov.ru/

Николаевский Е.Н. Инфекционный эндокардит как медико-социальная проблема современной России. Новая Наука Стратегии и Векторы Развития. 2016;6-2:26-9.

Nikolaevsky EN. Infective endocarditis as a medical and social problem of modern Russia. Novaya Nauka Strategii i Vektory Razvitiya. 2016;6-2:26-9. (In Russ.)

Aksoy O, Sexton DJ, Wang A, et al. Early Surgery in Patients with Infective Endocarditis: A Propensity Score Analysis. Clin Infect Dis. 2007;44:364-72. doi:10.1086/510583.

Chirouze C, Cabell CH, Fowler VG, et al. Prognostic Factors in 61 Cases of Staphylococcus aureus Prosthetic Valve Infective Endocarditis from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis. 2004;38:1323-7. doi:10.1086/383035.

Демин А.А., Дробышева В. П., Вельтер О.Ю. Инфекционный эндокардит внутривенных наркоманов. Клин Мед. 2000;78:47-51.

Demin AA, Drobysheva VP, Velter OYu. Infective endocarditis in "injection drug addicts" Clin med. 2000;78;47-51. (In Russ.)

Aggarwal N, Suri V, Kaur H, et al. Retrospective analysis of outcome of pregnancy in women with congenital heart disease: Single-centre experience from North India. Aust New Zeal J Obstet Gynaecol. 2009;49:376-81. doi:10.1111/j.1479-828X.2009.01029.x.

Akhyari P, Mehrabi A, Adhiwana A, et al. Is simultaneous splenectomy an additive risk factor in surgical treatment for active endocarditis? Langenbeck’s Arch Surg. 2012;397:1261-6. doi:10.1007/s00423-012-0931-y.

Муратов Р.М. Инфекционный эндокардит (ИЭ). Клинические Рекомендации Министерства Здравоохранения Российской Федерации. Москва. 2016, p.50.

Muratov R.M. Infective endocarditis (IE). Clinical Recommendations of the Ministry of Health of the Russian Federation. Moscow. 2016, p.50. (In Russ.)

McDonald JR. Acute Infective Endocarditis. Infect Dis Clin North Am. 2009;23:643-64. doi:10.1016/j.idc.2009.04.013.

Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Hear Rhythm. 2017;14:e503-51. doi:10.1016/j.hrthm.2017.09.001.

Федорова Т.А., Тазина С.Я., Семененко Н.А. и др. Актуальные проблемы инфекционного эндокардита. Вестник Национального Медико-Хирургического Центра Им НИ Пирогова. 2014:125-7.

Fedorova TA, Tazina SYa, Semenenko NA, et al. Actual problems of infective endocarditis. Vestnik Nacional’nogo Mediko-Hirurgicheskogo Centra Im NI Pirogova. 2014:125-7. (In Russ.)

Thuny F, Disalvo G, Belliard O, et al. Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography. Circulation. 2005;112:69-75. doi:10.1161/CIRCULATIONAHA.104.493155.

Habib G, Derumeaux G, Avierinos J-F, et al. Value and limitations of the duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33:2023-9. doi:10.1016/S0735-1097(99)00116-3.

Durack DT, Lukes AS, Bright DK. Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96:200-9. doi:10.1016/0002-9343(94)90143-0.

Cecchi E, Trinchero R, Imazio M, et al. Are the Duke criteria really useful for the early bedside diagnosis of infective endocarditis? Results of a prospective multicenter trial. Ital Heart J. 2005;6:41-8.

Li JS, Sexton DJ, Mick N, et al. Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis. Clin Infect Dis. 2000;30:633-8. doi:10.1086/313753.

Hill EE, Herijgers P, Claus P, et al. Abscess in infective endocarditis: The value of transesophageal echocardiography and outcome. Am Heart J. 2007;154:923-8. doi:10.1016/j.ahj.2007.06.028.

Vieira M. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart. 2004;90:1020-4. doi:10.1136/hrt.2003.025585.

Bruun NE, Habib G, Thuny F, Sogaard P. Cardiac imaging in infectious endocarditis. Eur Heart J. 2014;35:624-32. doi:10.1093/eurheartj/eht274.

Thuny F, Gaubert J-Y, Jacquier A, et al. Imaging investigations in infective endocarditis: Current approach and perspectives. Arch Cardiovasc Dis. 2013;106:52-62. doi:10.1016/j.acvd.2012.09.004.

Sarrazin J-F, Philippon F, Tessier M, et al. Usefulness of Fluorine-18 Positron Emission Tomography/Computed Tomography for Identification of Cardiovascular Implantable Electronic Device Infections. J Am Coll Cardiol. 2012;59:1616-25. doi:10.1016/j.jacc.2011.11.059.

Liesman RM, Pritt BS, Maleszewski JJ, Patel R. Laboratory Diagnosis of Infective Endocarditis. J Clin Microbiol. 2017;55:2599-608. doi:10.1128/JCM.00635-17.

San Román JA, Vilacosta I, López J. Comments on: ‘The infective endocarditis team: recommendations from an international working group.’ Heart. 2014;100:1301.2-1302. doi:10.1136/heartjnl-2014-306230.

Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Thorac Cardiovasc Surg. 2014;148:e1-132. doi:10.1016/j.jtcvs.2014.05.014.

Shakya S, Hussain S, Gordon S, et al. Clinical Presentation of Infective Endocarditis in the Early 21st Century: A Descriptive Study. Open Forum Infect Dis. 2017;4:S559-S559. doi:10.1093/ofid/ofx163.1456.

Habib G, Lancellotti P, Erba P-A, et al. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Hear J Qual Care Clin Outcomes. 2019;5:202-7. doi:10.1093/ehjqcco/qcz018.

Ducruet AF, Hickman ZL, Zacharia BE et al. Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev. 2010;33:37. doi:10.1007/s10143-009-0233-1.

Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association. J Am Dent Assoc. 2007;138:739-60. doi:10.14219/jada.archive.2007.0262.

Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435-86. doi:10.1161/CIR.0000000000000296.

Lamy B, Dargère S, Arendrup MC, et al. How to Optimize the Use of Blood Cultures for the Diagnosis of Bloodstream Infections? A State-of-the Art. Front Microbiol. 2016;7:697. doi:10.3389/fmicb.2016.00697.

Котова Е.О., Домонова Э.А., Кобалава Ж.Д., и др. Инфекционный эндокардит неустановленной этиологии: возможности преодоления и роль микробиологистики. Кардиология. 2021;61(1):87-97. doi:10.18087/cardio.2021.1.n1218.

Kotova EO, Domonova EA, Kobalava ZD, et al. Infective Endocarditis with Unknown Etiology: Possibilities of Conquering and Role of Microbiologistics. Kardiologiia. 2021;61(1):87-97. (In Russ.) doi:10.18087/cardio.2021.1.n1218.

La Scola B, Raoult D. Direct Identification of Bacteria in Positive Blood Culture Bottles by Matrix-Assisted Laser Desorption Ionisation Time-of-Flight Mass Spectrometry. PLoS One 2009;4:e8041. doi:10.1371/journal.pone.0008041.

Rodríguez-Sánchez B, Sánchez-Carrillo C, Ruiz A, et al. Direct identification of pathogens from positive blood cultures using matrix-assisted laser desorption-ionization timeof-flight mass spectrometry. Clin Microbiol Infect. 2014;20:O421-7. doi:10.1111/1469-0691.12455.

Fournier P, Thuny F, Richet H, et al. Comprehensive Diagnostic Strategy for Blood Culture–Negative Endocarditis: A Prospective Study of 819 New Cases. Clin Infect Dis. 2010;51:131-40. doi:10.1086/653675.

Lamas CC, Fournier P-E, Zappa M, et al. Diagnosis of blood culture-negative endocarditis and clinical comparison between blood culture-negative and blood culture-positive cases. Infection. 2016;44:459-66. doi:10.1007/s15010-015-0863-x.

Котова Е.О., Домонова Э.А., Караулова Ю.Л., и др. Инфекционный эндокардит: значение молекулярно-биологических методов в этиологической диагностике. Терапевтический архив. 2016:11,62-7. doi:10.17116/terarkh2016881162-67.

Kotova EO, Domonova EA, Karaulova YL, et al. Infective endocarditis: Importance of molecular biological techniques in etiological diagnosis. Ter Arkh. 2016;88:62-7. (In Russ.) doi:10.17116/terarkh2016881162-67.

Tattevin P, Watt G, Revest M, et al. Update on blood culture-negative endocarditis. Médecine Mal Infect. 2015;45:1-8. doi:10.1016/j.medmal.2014.11.003.

Loyens M, Thuny F, Grisoli D, et al. Link between endocarditis on porcine bioprosthetic valves and allergy to pork. Int J Cardiol. 2013;167:600-2. doi:10.1016/j.ijcard.2012.09.233.

Fillâtre P, Gacouin A, Revest M, et al. Determinants and consequences of positive valve culture when cardiac surgery is performed during the acute phase of infective endocarditis. Eur J Clin Microbiol Infect Dis. 2020;39:629-35. doi:10.1007/s10096-019-03764-z.

Fernández G, Álvarez B, Manzarbeitia F, Renedo G. Infective endocarditis at autopsy: A review of pathologic manifestations and clinical correlates. Medicine (Baltimore) 2012;91:152-64. doi:10.1097/MD.0b013e31825631ea.

Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, et al. Infective Endocarditis After Transcatheter Aortic Valve Implantation. Circulation. 2015;131:1566-74. doi:10.1161/CIRCULATIONAHA.114.014089.

Habib G, Badano L, Tribouilloy C, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010;11:202-19. doi:10.1093/ejechocard/jeq004.

Yuan XC, Liu M, Hu J, et al. Diagnosis of infective endocarditis using echocardiography. Med (United States) 2019;98. doi:10.1097/MD.0000000000017141.

Алехин М.Н., Рыбакова М.К., Сидоренко Б.А., Буткевич О.М. Значение эхокардиографии в диагностике инфекционного эндокардита. Кардиология. 2005:4-13.

Alekhin MN, Rybakova MK, Sidorenko BA, Butkevich OM. The value of echocardiography in the diagnosis of infective endocarditis. Kardiologiya. 2005:4-13. (In Russ.)

Bai AD, Steinberg M, Showler A, et al. Diagnostic Accuracy of Transthoracic Echocardiography for Infective Endocarditis Findings Using Transesophageal Echocardiography as the Reference Standard: A Meta-Analysis. J Am Soc Echocardiogr. 2017;30:639-46.e8. doi:10.1016/j.echo.2017.03.007.

Bonzi M, Cernuschi G, Solbiati M, et al. Diagnostic accuracy of transthoracic echocardiography to identify native valve infective endocarditis: a systematic review and meta-analysis. Intern Emerg Med. 2018;13:937-46. doi:10.1007/s11739-018-1831-0.

Afonso L, Kottam A, Reddy V, Penumetcha A. Echocardiography in Infective Endocarditis: State of the Art. Curr Cardiol Rep. 2017;19:1-13. doi:10.1007/s11886-017-0928-9.

Eudailey K, Lewey J, Hahn RT, George I. Aggressive infective endocarditis and the importance of early repeat echocardiographic imaging. J Thorac Cardiovasc Surg. 2014;147:e26-8. doi:10.1016/j.jtcvs.2013.10.069.

Incani A, Hair C, Purnell P, et al. Staphylococcus aureus bacteraemia: evaluation of the role of transoesophageal echocardiography in identifying clinically unsuspected endocarditis. Eur J Clin Microbiol Infect Dis. 2013;32:1003-8. doi:10.1007/s10096-013-1838-4.

Rasmussen RV, Host U, Arpi M, et al. Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. Eur J Echocardiogr. 2011;12:414-20. doi:10.1093/ejechocard/jer023.

Koslow M, Kuperstein R, Eshed I, et al. The Unique Clinical Features and Outcome of Infectious Endocarditis and Vertebral Osteomyelitis Co-infection. Am J Med. 2014;127:669. e9-669.e15. doi:10.1016/j.amjmed.2014.02.023.

Carbone A, Mouhat B, Philip M, et al. Spondylitis: A frequent and severe complication of infective endocarditis. Arch Cardiovasc Dis Suppl. 2020;12:82. doi:10.1016/j.acvdsp.2019.09.174.

Shapira Y, Weisenberg DE, Vaturi M, et al. The impact of intraoperative transesophageal echocardiography in infective endocarditis. Isr Med Assoc J. 2007;9:299-302.

Berdejo J, Shibayama K, Harada K, et al. Evaluation of Vegetation Size and Its Relationship With Embolism in Infective Endocarditis. Circ Cardiovasc Imaging. 2014;7:149-54. doi:10.1161/CIRCIMAGING.113.000938.

Pfister R, Betton Y, ten Freyhaus H, et al. Three-dimensional compared to two-dimensional transesophageal echocardiography for diagnosis of infective endocarditis. Infection. 2016;44:725-31. doi:10.1007/s15010-016-0908-9.

Feuchtner GM, Stolzmann P, Dichtl W, et al. Multislice Computed Tomography in Infective Endocarditis. J Am Coll Cardiol. 2009;53:436-44. doi:10.1016/j.jacc.2008.01.077.

Rajani R, Klein JL. Infective endocarditis: A contemporary update. Clin Med J R Coll Physicians London. 2020;20:31-5. doi:10.7861/clinmed.cme.20.1.1.

Georges H, Leroy O, Airapetian N, et al. Outcome and prognostic factors of patients with right-sided infective endocarditis requiring intensive care unit admission. BMC Infect Dis. 2018;18:85. doi:10.1186/s12879-018-2989-9.

Colen TW, Gunn M, Cook E, Dubinsky T. Radiologic manifestations of extra-cardiac complications of infective endocarditis. Eur Radiol. 2008;18:2433-45. doi:10.1007/s00330-008-1037-3.

Fagman E, Perrotta S, Bech-Hanssen O, et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol. 2012;22:2407-14. doi:10.1007/s00330-012-2491-5.

Grob A, Thuny F, Villacampa C, et al. Cardiac multidetector computed tomography in infective endocarditis: a pictorial essay. Insights Imaging 2014;5:559-70. doi:10.1007/s13244-014-0353-1.

Goddard A, Tan G, Becker J. Computed tomography angiography for the detection and characterization of intra-cranial aneurysms: Current status. Clin Radiol. 2005;60:1221-36. doi:10.1016/j.crad.2005.06.007.

Iung B, Tubiana S, Klein I, et al. Determinants of Cerebral Lesions in Endocarditis on Systematic Cerebral Magnetic Resonance Imaging. Stroke 2013;44:3056-62. doi:10.1161/STROKEAHA.113.001470.

Goulenok T, Klein I, Mazighi M, et al. Infective Endocarditis with Symptomatic Cerebral Complications: Contribution of Cerebral Magnetic Resonance Imaging. Cerebrovasc Dis. 2013;35:327-36. doi:10.1159/000348317.

Hess A, Klein I, Iung B, et al. Brain MRI Findings in Neurologically Asymptomatic Patients with Infective Endocarditis. Am J Neuroradiol 2013;34:1579-84. doi:10.3174/ajnr.A3582.

Duval X. Effect of Early Cerebral Magnetic Resonance Imaging on Clinical Decisions in Infective Endocarditis. Ann Intern Med 2010;152:497. doi:10.7326/0003-4819-152-8-201004200-00006.

White PM, Teasdale EM, Wardlaw JM, Easton V. Intracranial Aneurysms: CT Angiography and MR Angiography for Detection — Prospective Blinded Comparison in a Large Patient Cohort. Radiology. 2001;219:739-49. doi:10.1148/radiology.219.3.r01ma16739.

Hui FK, Bain M, Obuchowski NA, et al. Mycotic aneurysm detection rates with cerebral angiography in patients with infective endocarditis. J Neurointerv Surg. 2015;7:449-52. doi:10.1136/neurintsurg-2014-011124.

Palestro CJ, Brown ML, Forstrom L, et al. Society of Nuclear Medicine Procedure Guideline for 99mTc-Exametazime (HMPAO)-Labeled Leukocyte Scintigraphy for Suspected Infection/Inflammation. Soc Nucl Med Proced Guidel. 2004:1-6.

Rouzet F, Chequer R, Benali K, et al. Respective Performance of 18F-FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis. J Nucl Med. 2014;55:1980-5. doi:10.2967/jnumed.114.141895.

Erba PA, Pizzi MN, Roque A, et al. Multimodality Imaging in Infective Endocarditis. Circulation 2019;140:1753-65. doi:10.1161/CIRCULATIONAHA.119.040228.

Kircher M, Lapa C. Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation. Curr Cardiovasc Imaging Rep. 2017;10. doi:10.1007/s12410-017-9400-x.

Бокерия Л.А., Асланиди И.П., Пурсанова Д.М., и др. Диагностика электродного инфекционного эндокардита методом ПЭТ/КТ с 18F-фтордезоксиглюкозой. Анналы Аритмологии. 2019;16(1):22-7.

Bokeria LA, Aslanidi IP, Pursanova DM et al. Diagnosis of electrode infective endocarditis by PET/CT with 18F-fluorodeoxyglucose. Annaly Aritmologii. 2019;16(1):22-7. (In Russ.)

Mahmood M, Kendi AT, Ajmal S, et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol. 2019;26:922-35. doi:10.1007/s12350-017-1092-8.

Erba PA, Conti U, Lazzeri E, et al. Added Value of 99mTc-HMPAO-Labeled Leukocyte SPECT/CT in the Characterization and Management of Patients with Infectious Endocarditis. J Nucl Med. 2012;53:1235-43. doi:10.2967/jnumed.111.099424.

Bensimhon L, Lavergne T, Hugonnet F, et al. Whole body [18F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. Clin Microbiol Infect. 2011;17:836-44. doi:10.1111/j.1469-0691.2010.03312.x.

Бокерия Л.А., Асланиди И.П., Пурсанова Д.М., и др. Возможности ПЭТ/КТ с 18F-фтордезоксиглюкозой в диагностике инфекционных процессов, связанных с имплантированными внутрисердечными устройствами. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. Сердечно-сосудистые заболевания. 2019;20(6):498-508. doi:10.24022/1810-0694-2019-20-6-498-508.

Bockeria LA, Aslanidi IP, Pursanova DM, et al. 18F-fluorodeoxyglucose PET/CT in diagnostics of infectice endocarditis in patients with implantable cardiac devices. Bull Bakoulev Cent "Cardiovascular Dis. 2019;20(6):498-508. (In Russ.) doi:10.24022/1810-0694-2019-20-6-498-508.

Erba PA, Sollini M, Conti U, Bandera F, Tascini C, De Tommasi SM, et al. Radiolabeled WBC Scintigraphy in the Diagnostic Workup of Patients With Suspected Device-Related Infections. JACC Cardiovasc Imaging. 2013;6:1075-86. doi:10.1016/j.jcmg.2013.08.001.

Vind SH, Hess S. Possible role of PET/CT in infective endocarditis. J Nucl Cardiol. 2010;17:516-9. doi:10.1007/s12350-009-9174-x.

Pigrau C, Almirante B, Flores X, et al. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: Incidence, risk factors, and outcome. Am J Med. 2005;118:1287.e17-1287. e24. doi:10.1016/j.amjmed.2005.02.027.

Tamura K. Clinical characteristics of infective endocarditis with vertebral osteomyelitis. J Infect Chemother. 2010;16:260-5. doi:10.1007/s10156-010-0046-8.

Parra JA, Hernández L, Muñoz P, et al. Detection of spleen, kidney and liver infarcts by abdominal computed tomography does not affect the outcome in patients with left-side infective endocarditis. Med (United States) 2018;97:e11952. doi:10.1097/MD.0000000000011952.

Chou YH, Hsu CC, Tiu CM, Chang T. Splenic abscess: Sonographic diagnosis and percutaneous drainage or aspiration. Gastrointest Radiol. 1992;17:262-6. doi:10.1007/BF01888563.

Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451-96. doi:10.1093/eurheartj/ehs109.

100

Nunes MCP, Guimarães-Júnior MH, Murta Pinto PHO, et al. Outcomes of infective endocarditis in the current era: Early predictors of a poor prognosis. Int J Infect Dis. 2018;68:102-7. doi:10.1016/j.ijid.2018.01.016.

101

Davierwala PM, Marin-Cuartas M, Misfeld M, Borger MA. The value of an "Endocarditis Team." Ann Cardiothorac Surg. 2019;8:621-9. doi:10.21037/acs.2019.09.03.

102

López J, Sevilla T, Vilacosta I, et al. Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis. Eur Heart J. 2013;34:1749-54. doi:10.1093/eurheartj/ehs379.

103

Nashef SAM, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734-45. doi:10.1093/ejcts/ezs043.

104

Correction. Circulation. 2005;112(15):2374-4. doi:10.1161/CIRCULATIONAHA.105.167943.

105

Najmeddin F, Khalili H. Comment on: Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2012;67:3016-7. doi:10.1093/jac/dks290.

106

Nordström L, Ringbert H, Cronberg S, et al. Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity? J Antimicrob Chemother. 1990;25:159-73. doi:10.1093/jac/25.1.159.

107

Lebeaux D, Fernández-Hidalgo N, Pilmis B, et al. Aminoglycosides for infective endocarditis: time to say goodbye? Clin Microbiol Infect. 2020;26:723-8. doi:10.1016/j.cmi.2019.10.017.

108

Cosgrove SE, Vigliani GA, Campion M, et al. Initial Low‐Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic. Clin Infect Dis. 2009;48:713-21. doi:10.1086/597031.

109

Cremieux AC, Maziere B, Vallois JM, et al. Evaluation of Antibiotic Diffusion into Cardiac Vegetations by Quantitative Autoradiography. J Infect Dis. 1989;159:938-44. doi:10.1093/infdis/159.5.938.

110

Miró JM, García-de-la-Mària C, Armero Y, et al. Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009;53:4172-7. doi:10.1128/AAC.00051-09.

111

Garrigós C, Murillo O, Lora-Tamayo J, et al. Fosfomycin-Daptomycin and Other Fosfomycin Combinations as Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2013;57:606-10. doi:10.1128/AAC.01570-12.

112

Veganzones J, Montero A, Maseda E. New evidence on the use of fosfomycin for bacteremia and infectious endocarditis. Rev Esp Quimioter. 2019;32:25-9.

113

Fowler VG, Boucher HW, Corey GR, et al. Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-65. doi:10.1056/NEJMoa053783.

114

Miró JM, Entenza JM, del Río A, al. High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis. Antimicrob Agents Chemother. 2012;56:4511-5. doi:10.1128/AAC.06449-11.

115

Shaw E, Miró JM, Puig-Asensio M, et al. Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: Protocol of a multicentre, randomised, phase III trial. BMJ Open. 2015;5. doi:10.1136/bmjopen-2014-006723.

116

Grillo S, Cuervo G, Carratalà J, et al. Impact of β-Lactam and Daptomycin Combination Therapy on Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Bacteremia: A Propensity Score–matched Analysis. Clin Infect Dis. 2019;69:1480-8. doi:10.1093/cid/ciz018.

117

Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 Days: A prospective multicenter study. Clin Infect Dis. 1995;21:1406–10. doi:10.1093/clinids/21.6.1406.

118

Majumdar A, Chowdhary S, Ferreira MA, et al. Renal pathological findings in infective endocarditis. Nephrol Dial Transplant. 2000;15:1782-7. doi:10.1093/ndt/15.11.1782.

119

Ritchie BM, Hirning BA, Stevens CA, et al. Risk factors for acute kidney injury associated with the treatment of bacterial endocarditis at a tertiary academic medical center. J Chemother. 2017;29:292-8. doi:10.1080/1120009X.2017.1296916.

120

Sexton DJ, Tenenbaum MJ, Wilson WR, et al. Ceftriaxone Once Daily for Four Weeks Compared with Ceftriaxone Plus Gentamicin Once Daily for Two Weeks for Treatment of Endocarditis Due to Penicillin‐Susceptible Streptococci. Clin Infect Dis. 1998;27:1470-4. doi:10.1086/515038.

121

Francioli P, Etienne J, Hoigné R, et al. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA. 1992;267(2):264-7. doi:10.1001/jama.1992.03480020074034.

122

Gould FK, Denning DW, Elliott TSJ, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: A report of the working party of the british society for antimicrobial chemotherapy. J Antimicrob Chemother. 2012;67:269-89. doi:10.1093/jac/dkr450.

123

Martino P, Venditti M, Micozzi A, et al. Teicoplanin in the treatment of gram-positivebacterial endocarditis. Antimicrob Agents Chemother. 1989;33:1329-34. doi:10.1128/AAC.33.8.1329.

124

Lewis PJ, Martino P, Mosconi G, Harding I. Teicoplanin in endocarditis: A multicentre, open european study. Chemotherapy. 1995;41:399-411. doi:10.1159/000239373.

125

Brett MS. Emergence of a high-level cefotaxime-resistant Streptococcus pneumoniae strain in New Zealand. J Med Microbiol. 2001;50:173-6. doi:10.1099/0022-1317-50-2-173.

126

Martínez E, Miró JM, Almirante B, et al. Effect of Penicillin Resistance of Streptococcus pneumoniae on the Presentation, Prognosis, and Treatment of Pneumococcal Endocarditis in Adults. Clin Infect Dis. 2002;35:130-9. doi:10.1086/341024.

127

Sambola A, Miro JM, Tornos MP, et al. Streptococcus agalactiae Infective Endocarditis: Analysis of 30 Cases and Review of the Literature, 1962-1998. Clin Infect Dis. 2002;34:1576-84. doi:10.1086/340538.

128

Gavaldà J, Pahissa A, Almirante B, et al. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin. Antimicrob Agents Chemother. 1995;39(9):2098-103. doi:10.1128/AAC.39.9.2098.

129

Giuliano S, Caccese R, Carfagna P, et al. Endocarditis caused by nutritionally variant streptococci: A case report and literature review. Infez Med. 2012;20:67-74.

130

Adam EL, Siciliano RF, Gualandro DM, et al. Case series of infective endocarditis caused by Granulicatella species. Int J Infect Dis. 2015;31:56-8. doi:10.1016/j.ijid.2014.10.023.

131

Fortún J, Navas E, Martínez‐Beltrán J, et al. Short‐Course Therapy for Right‐Side Endocarditis Due to Staphylococcus aureus in Drug Abusers: Cloxacillin versus Glycopeptides in Combination with Gentamicin. Clin Infect Dis. 2001;33:120-5. doi:10.1086/320869.

132

DiNubile MJ. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med. 1994;121:873-6. doi:10.7326/0003-4819-121-11-199412010-00009.

133

Smith JR, Claeys KC, Barber KE, Rybak MJ. High-Dose Daptomycin Therapy for Staphylococcal Endocarditis and When to Apply It. Curr Infect Dis Rep. 2014;16. doi:10.1007/s11908-014-0429-6.

134

Guleri A, Utili R, Dohmen P, et al. Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin® Outcomes Registry and Experience (EU-CORE). Infect Dis Ther. 2015;4:283-96. doi:10.1007/s40121-015-0075-9.

135

Tissot-Dupont H, Gouriet F, Oliver L, et al. High-dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis. Int J Antimicrob Agents. 2019;54:143-8. doi:10.1016/j.ijantimicag.2019.06.006.

136

Taha L, Stegger M, Söderquist B. Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options. Eur J Clin Microbiol Infect Dis. 2019;38:1449-55. doi:10.1007/s10096-019-03571-6.

137

Siciliano RF, Randi BA, Gualandro DM, et al. Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Infect Dis. 2018;67:3-6. doi:10.1016/j.ijid.2017.09.004.

138

Dhand A, Bayer AS, Pogliano J, et al. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillinresistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis. 2011;53:158-63. doi:10.1093/cid/cir340.

139

Pericàs JM, Moreno A, Almela M, et al. Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillinresistant Staphylococcus aureus: a randomized clinical trial. Clin Microbiol Infect. 2018;24:673-6. doi:10.1016/j.cmi.2018.01.010.

140

Zasowski EJ, Trinh TD, Claeys KC, et al. Multicenter observational study of ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2017;61. doi:10.1128/AAC.02015-16.

141

Watkins RR, Lemonovich TL, File TM. An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): Place in therapy. Core Evid. 2012;7:131-43. doi:10.2147/CE.S33430.

142

Jang H, Kim S, Kim KH, et al. Salvage Treatment for Persistent Methicillin‐Resistant Staphylococcus aureus Bacteremia: Efficacy of Linezolid With or Without Carbapenem. Clin Infect Dis. 2009;49:395-401. doi:10.1086/600295.

143

Périchon B, Courvalin P. Synergism between β-Lactams and Glycopeptides against VanAType Methicillin-Resistant Staphylococcus aureus and Heterologous Expression of the vanA Operon. Antimicrob Agents Chemother. 2006;50:3622-30. doi:10.1128/AAC.00410-06.

144

Bartash R, Nori P. Beta-lactam combination therapy for the treatment of Staphylococcus aureus and Enterococcus species bacteremia: A summary and appraisal of the evidence. Int J Infect Dis. 2017;63:7-12. doi:10.1016/j.ijid.2017.07.019.

145

Casalta J-P, Zaratzian C, Hubert S, et al. Treatment of Staphylococcus aureus endocarditis with high doses of trimethoprim/sulfamethoxazole and clindamycin-Preliminary report. Int J Antimicrob Agents. 2013;42:190-1. doi:10.1016/j.ijantimicag.2013.05.002.

146

Berrington A. Treatment of endocarditis using moxifloxacin. Int J Med Microbiol. 2001;291:237-9. doi:10.1078/1438-4221-00126.

147

Entenza JM, Que YA, Vouillamoz J, et al. Efficacies of Moxifloxacin, Ciprofloxacin, and Vancomycin against Experimental Endocarditis Due to Methicillin-ResistantStaphylococcus aureus Expressing Various Degrees of Ciprofloxacin Resistance. Antimicrob Agents Chemother. 2001;45:3076-83. doi:10.1128/AAC.45.11.3076-3083.2001.

148

Nigo M, Munita JM, Arias CA, Murray BE. What’s New in the Treatment of Enterococcal Endocarditis? Curr Infect Dis Rep. 2014;16:431. doi:10.1007/s11908-014-0431-z.

149

Beganovic M, Luther MK, Rice LB, et al. A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis. Clin Infect Dis. 2018;67(2):303-9. doi:10.1093/cid/ciy064.

150

Miro JM, Pericas JM, Del Rio A. A new era for treating enterococcus faecalis endocarditis ampicillin plus short-course gentamicin or ampicillin plus ceftriaxone: That is the question! Circulation. 2013;127:1763-6. doi:10.1161/CIRCULATIONAHA.113.002431.

151

Falcone M, Russo A, Venditti M. Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: New insights and evidence from the literature. J Infect Chemother. 2015;21:330-9. doi:10.1016/j.jiac.2015.02.012.

152

Pontikis K, Pefanis A, Tsaganos T, et al. Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2013;57:3392-4. doi:10.1128/AAC.00646-13.

153

Coburn B, Toye B, Rawte P, et al. Antimicrobial susceptibilities of clinical isolates of HACEK organisms. Antimicrob Agents Chemother. 2013;57:1989-91. doi:10.1128/AAC.00111-13.

154

Choi HN, Park KH, Park S, et al. Prosthetic valve endocarditis caused by HACEK organisms: A case report and systematic review of the literature. Infect Chemother. 2017;49:282-5. doi:10.3947/ic.2017.49.4.282.

155

Das M, Badley AD, Cockerill FR, et al. Infective endocarditis caused by HACEK microorganisms. Annu Rev Med. 1997;48:25-33. doi:10.1146/annurev.med.48.1.25.

156

Paturel L, Casalta JP, Habib G, et al. Actinobacillus actinomycetemcomitans endocarditis. Clinical Microbiology and Infection. 2004;10:98-118. doi:10.1111/j.1469-0691.2004.00794.x

157

Durante-Mangoni E, Tripodi MF, Albisinni R, Utili R. Management of Gramnegative and fungal endocarditis. Int J Antimicrob Agents. 2010;36. doi:10.1016/j.ijantimicag.2010.11.012.

158

Ertugrul Mercan M, Arslan F, Ozyavuz Alp S, et al. Non-HACEK Gram-negative bacillus endocarditis. Med Mal Infect. 2019;49:616-20. doi:10.1016/j.medmal.2019.03.013.

159

Steinbach WJ, Perfect JR, Cabell CH, et al. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230-47. doi:10.1016/j.jinf.2004.10.016.

160

Cornely OA, Lasso M, Betts R, et al. Caspofungin for the treatment of less common forms of invasive candidiasis. J Antimicrob Chemother. 2007;60:363-9. doi:10.1093/jac/dkm169.

161

Tattevin P, Revest M, Lefort A, et al. Fungal endocarditis: current challenges. Int J Antimicrob Agents. 2014;44:290-4. doi:10.1016/j.ijantimicag.2014.07.003.

162

Ahuja T, Fong K, Louie E. Combination antifungal therapy for treatment of Candida parapsilosis prosthetic valve endocarditis and utility of T2Candida Panel®: A case series. IDCases 2019;15:e00525. doi:10.1016/j.idcr.2019.e00525.

163

Gardiner BJ, Slavin MA, Korman TM, Stuart RL. Hampered by historical paradigms — echinocandins and the treatment of Candida endocarditis. Mycoses. 2014;57:316-9. doi:10.1111/MYC.12154.

164

Reyes HA, Carbajal WH, Valdez LM, Lozada C. Successful medical treatment of infective endocarditis caused by Candida parapsilosis in an immunocompromised patient. BMJ Case Rep. 2015;2015. doi:10.1136/BCR-2015-212128.

165

Bezerra LS, Silva JA, Santos-Veloso MA, et al. Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review. Brazilian J Cardiovasc Surg. 2020:1-8. doi:10.21470/1678-9741-2019-0159.

166

Reis LJ, Barton TD, Pochettino A, et al. Successful Treatment of Aspergillus Prosthetic Valve Endocarditis with Oral Voriconazole. Clin Infect Dis. 2005;41:752-3. doi:10.1086/432580.

167

Lennard K, Bannan A, Grant P, Post J. Potential benefit of combination antifungal therapy in Aspergillus endocarditis. BMJ Case Rep. 2020;13:e234008. doi:10.1136/bcr-2019-234008.

168

Lye DCB, Hughes A, O’Brien D, Athan E. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. Eur J Clin Microbiol Infect Dis. 2005;24:753-5. doi:10.1007/s10096-005-0038-2.

169

Pericàs JM, Llopis J, González-Ramallo V, et al. Outpatient Parenteral Antibiotic Treatment for Infective Endocarditis: A Prospective Cohort Study From the GAMES Cohort. Clin Infect Dis. 2019;69:1690-700. doi:10.1093/cid/ciz030.

170

Iversen K, Ihlemann N, Gill SU, et al. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis. N Engl J Med. 2019;380:415-24. doi:10.1056/NEJMoa1808312.

171

García-Cabrera E, Fernández-Hidalgo N, Almirante B, et al. Neurological Complications of Infective Endocarditis. Circulation. 2013;127:2272-84. doi:10.1161/CIRCULATIONAHA.112.000813.

172

Fernández-Hidalgo N, Almirante B, Tornos P, et al. Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital. Clin Microbiol Infect. 2012;18:E522-30. doi:10.1111/1469-0691.12033.

173

Ong E, Mechtouff L, Bernard E, et al. Thrombolysis for stroke caused by infective endocarditis: an illustrative case and review of the literature. J Neurol. 2013;260:1339-42. doi:10.1007/s00415-012-6802-1.

174

Connolly DL, Choudhury A, Davis RC, Lip GYH. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2004;43:1134-5. doi:10.1016/j.jacc.2003.12.025.

175

Kupferwasser LI, Yeaman MR, Shapiro SM, et al. Acetylsalicylic Acid Reduces Vegetation Bacterial Density, Hematogenous Bacterial Dissemination, and Frequency of Embolic Events in Experimental Staphylococcus aureus Endocarditis Through Antiplatelet and Antibacterial Effects. Circulation. 1999;99:2791-7. doi:10.1161/01.CIR.99.21.2791.

176

Anavekar NS, Tleyjeh IM, Anavekar NS, et al. Impact of Prior Antiplatelet Therapy on Risk of Embolism in Infective Endocarditis. Clin Infect Dis. 2007;44:1180-6. doi:10.1086/513197.

177

Habib A, Irfan M, Baddour LM, et al. Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace. 2013;15:227-35. doi:10.1093/europace/eus292.

178

Chan K-L, Tam J, Dumesnil JG, et al. Effect of Long-Term Aspirin Use on Embolic Events in Infective Endocarditis. Clin Infect Dis. 2008;46:37-41. doi:10.1086/524021.

179

Snygg-Martin U, Rasmussen RV, Hassager C, et al. The relationship between cerebrovascular complications and previously established use of antiplatelet therapy in leftsided infective endocarditis. Scand J Infect Dis. 2011:899-904.

180

Поляков В.П., Николаевский Е.Н., Хубулава Г.Г. и др. Инфекционный эндокардит (современное состояние проблемы). Монография. Самара: ООО ИПК "Содружество", 2007, p.340.

Polyakov VP, Nikolaevsky EN, Khubulava GG, et al. Infective endocarditis (current state of the problem). Samara: IPK Sodruzhestvo LLC; 2007, p.340. (In Russ.)

181

Di Salvo G. Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. Eur Heart J. 2003;24:1576-83. doi:10.1016/S0195-668X(03)00309-9.

182

Kiefer T, Park L, Tribouilloy C, et al. Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure. JAMA. 2011;306. doi:10.1001/jama.2011.1701.

183

Pettersson GB, Coselli JS, Pettersson GB, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary. J Thorac Cardiovasc Surg. 2017;153:1241-58.e29. doi:10.1016/j.jtcvs.2016.09.093.

184

Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011;32:2027-33. doi:10.1093/eurheartj/ehp089.

185

Chu VH, Park LP, Athan E, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis a prospective study from the international collaboration on endocarditis. Circulation. 2015;131:131-40. doi:10.1161/CIRCULATIONAHA.114.012461.

186

Kahveci G, Bayrak F, Mutlu B, et al. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Active Infective Endocarditis. Am J Cardiol. 2007;99:1429-33. doi:10.1016/j.amjcard.2006.12.071.

187

Purcell JB, Patel M, Khera A, et al. Relation of Troponin Elevation to Outcome in Patients With Infective Endocarditis. Am J Cardiol. 2008;101:1479-81. doi:10.1016/j.amjcard.2008.01.031.

188

Mügge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: Reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol. 1989;14:631-8. doi:10.1016/0735-1097(89)90104-6.

189

Piper C. The importance of secondary mitral valve involvement in primary aortic valve endocarditis. The mitral kissing vegetation. Eur Heart J. 2002;23:79-86. doi:10.1053/euhj.2001.2689.

190

Nadji G, Rusinaru D, Rémadi J-P, et al. Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail. 2009;11:668-75. doi:10.1093/eurjhf/hfp077.

191

Anguera I, Miro JM, Vilacosta I, et al. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J. 2005;26:288-97. doi:10.1093/eurheartj/ehi034.

192

Anguera I, Miro JM, Evangelista A, et al. Periannular complications in infective endocarditis involving native aortic valves. Am J Cardiol. 2006:1254-60.

193

Gahide G, Bommart S, Demaria R, et al. Preoperative Evaluation in Aortic Endocarditis: Findings on Cardiac CT. Am J Roentgenol. 2010;194:574-8. doi:10.2214/AJR.08.2120.

194

Chirouze C, Alla F, Fowler VG, et al. Impact of early valve surgery on outcome of staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the international collaboration of endocarditis-prospective cohort study. Clin Infect Dis. 2015;60:741-9. doi:10.1093/cid/ciu871.

195

Wang A. Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis. JAMA. 2007;297:1354. doi:10.1001/jama.297.12.1354.

196

Lee SJ, Jeon D, Cho WH, Kim YS. The Clinical Impacts of Apparent Embolic Event and the Predictors of In-Hospital Mortality in Patients with Infective Endocarditis. J Korean Med Sci. 2014;29:1646. doi:10.3346/jkms.2014.29.12.1646.

197

Wojda TR, Cornejo K, Lin A, et al. Septic Embolism: A Potentially Devastating Complication of Infective Endocarditis. In; Firstenberg M.S. Contemporary Challenges in Endocarditis. London: IntechOpen; 2016. 178 p. ISBN: 978-953-51-2770-3. doi:10.5772/62550.

198

Vilacosta I, Graupner C, SanRomán J, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol. 2002;39:1489-95. doi:10.1016/S0735-1097(02)01790-4.

199

Dickerman SA, Abrutyn E, Barsic B, et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J. 2007;154:1086-94. doi:10.1016/j.ahj.2007.07.023.

200

Houard V, Porte L, Delon C, et al. Prognostic value of residual vegetation after antibiotic treatment for infective endocarditis: A retrospective cohort study. Int J Infect Dis. 2020;94:34-40. doi:10.1016/j.ijid.2020.03.005.

201

Hubert S, Thuny F, Resseguier N, et al. Prediction of Symptomatic Embolism in Infective Endocarditis. J Am Coll Cardiol. 2013;62:1384-92. doi:10.1016/j.jacc.2013.07.029.

202

Delahaye F, Célard M, Roth O, de Gevigney G. Indications and optimal timing for surgery in infective endocarditis. Heart. 2004;90(6):618-20. doi:10.1136/hrt.2003.029967.

203

Kang D-H, Kim Y-J, Kim S-H, et al. Early Surgery versus Conventional Treatment for Infective Endocarditis. N Engl J Med. 2012;366:2466-73. doi:10.1056/NEJMoa1112843.

204

Mohananey D, Mohadjer A, Pettersson G, et al. Association of vegetation size with embolic risk in patients with infective endocarditis a systematic review and meta-analysis. JAMA Intern Med. 2018;178:502-10. doi:10.1001/jamainternmed.2017.8653.

205

Shapiro S, Kupferwasser LI. Echocardiography predicts embolic events in infective endocarditis. Journal of the American College of Cardiology. 2001;37(4):1077-9. doi:10.1016/S0735-1097(01)01149-4.

206

Thuny F, Avierinos J-F, Tribouilloy C, et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J. 2007;28:1155-61. doi:10.1093/eurheartj/ehm005.

207

Erdogan HB, Erentug V, Bozbuga N, et al C. Endovascular treatment of intracerebral mycotic aneurysm before surgical treatment of infective endocarditis. Texas Hear Inst J. 2004;31:165-7.

208

Ferro JM, Fonseca AC. Infective endocarditis. Handb. Clin. Neurol. 2014;119:75-91. doi:10.1016/B978-0-7020-4086-3.00007-2.

209

Morris NA, Matiello M, Lyons JL, Samuels MA. Neurologic Complications in Infective Endocarditis: Identification, Management, and Impact on Cardiac Surgery. The Neurohospitalist. 2014;4:213-22. doi:10.1177/1941874414537077.

210

Hosono M, Sasaki Y, Hirai H, et al. Considerations in timing of surgical intervention for infective endocarditis with cerebrovascular complications. J Heart Valve Dis. 2010;19:321-5.

211

Tam DY, Yanagawa B, Verma S, et al. Early vs Late Surgery for Patients With Endocarditis and Neurological Injury: A Systematic Review and Meta-analysis. Can J Cardiol. 2018;34:1185-99. doi:10.1016/j.cjca.2018.05.010.

212

Ruttmann E, Willeit J, Ulmer H, et al. Neurological Outcome of Septic Cardioembolic Stroke After Infective Endocarditis. Stroke. 2006;37:2094-9. doi:10.1161/01.STR.0000229894.28591.3f.

213

González I, Sarriá C, López J, et al. Symptomatic Peripheral Mycotic Aneurysms Due to Infective Endocarditis. Medicine (Baltimore). 2014;93:42-52. doi:10.1097/MD.0000000000000014.

214

Uranüs S, Alimoglu O. Splenic Abscess and Infarction — Rare Events for Which Surgery Is Mandatory. Eur Surg. 2003;35:326-6. doi:10.1007/s10353-003-0039-2.

215

de Kerchove L, Vanoverschelde J-L, Poncelet A, et al. Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability. Eur J Cardio-Thoracic Surg. 2007;31:592-9. doi:10.1016/j.ejcts.2007.01.002.

216

Рыбка М.М., Хинчагов Д.Я., Мумладзе К.В., Никулкина Е.С. Протоколы анестезиологического обеспечения рентгенэндоваскулярных и диагностических процедур, выполняемых у кардиохирургических пациентов различных возрастных групп. Методические рекомендации. М: издательство "НМИЦССХ им. А.Н. Бакулева" МЗ РФ, 2018, p.74. ISBN: 978-5-7982-0385-7.

Rybka MM, Khinchagov DYa, Mumladze KV, Nikulkina ES. Anesthesia protocols for endovascular and diagnostic procedures performed in cardiac surgery patients of various age groups. Guidelines. M: izdatel’stvo "NMICSSKH im. A.N. Bakuleva" MZ RF, 2018, p.74. (In Russ.). ISBN: 978-5-7982-0385-7.

217

Landoni G, Lomivorotov VV, Nigro Neto C, et al. Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery. N Engl J Med. 2019;380. doi:10.1056/nejmoa1816476.

218

Lopes S, Calvinho P, de Oliveira F, Antunes M. Allograft aortic root replacement in complex prosthetic endocarditis. Eur J Cardio-Thoracic Surg. 2007;32:126-30. doi:10.1016/j.ejcts.2007.01.076.

219

Musci M, Weng Y, Hübler M, et al. Homograft aortic root replacement in native or prosthetic active infective endocarditis: Twenty-year single-center experience. J Thorac Cardiovasc Surg. 2010;139:665-73. doi:10.1016/j.jtcvs.2009.07.026.

220

Thuny F, Grisoli D, Collart F, et al. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379:965-75. doi:10.1016/S0140-6736(11)60755-1.

221

Duval X, Alla F, Hoen B, et al. Estimated Risk of Endocarditis in Adults with Predisposing Cardiac Conditions Undergoing Dental Procedures With or Without Antibiotic Prophylaxis. Clin Infect Dis. 2006;42:e102-7. doi:10.1086/504385.

222

Thornhill MH, Jones S, Prendergast B, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J. 2018;39:586-95. doi:10.1093/eurheartj/ehx655.

223

David TE, Gavra G, Feindel CM, et al. Surgical treatment of active infective endocarditis: A continued challenge. J Thorac Cardiovasc Surg. 2007;133:144-9. doi:10.1016/j.jtcvs.2006.08.060.

224

Alagna L, Park LP, Nicholson BP, et al. Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis — Prospective Cohort Study. Clin Microbiol Infect. 2014;20:566-75. doi:10.1111/1469-0691.12395.

225

Lopez J, Revilla A, Vilacosta I, et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J. 2007;28:760-5. doi:10.1093/eurheartj/ehl486.

226

Horstkotte D. Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary The Task Force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J. 2004;25:267-76. doi:10.1016/j.ehj.2003.11.008.

227

Hagl C, Galla JD, Lansman SL, et al. Replacing the ascending aorta and aortic valve for acute prosthetic valve endocarditis: is using prosthetic material contraindicated? Ann Thorac Surg. 2002;74:S1781-5. doi:10.1016/S0003-4975(02)04142-5.

228

Tornos P, Almirante B, Olona M, et al. Clinical Outcome and Long-Term Prognosis of Late Prosthetic Valve Endocarditis: A 20-Year Experience. Clin Infect Dis. 1997;24:381-6. doi:10.1093/clinids/24.3.381.

229

Truninger K, Jost CHA, Seifert B, et al. Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone? Heart. 1999;82:714-20. doi:10.1136/hrt.82.6.714.

230

Hill EE, Herregods M-C, Vanderschueren S, et al. Management of Prosthetic Valve Infective Endocarditis. Am J Cardiol. 2008;101:1174-8. doi:10.1016/j.amjcard.2007.12.015.

231

Sohail MR, Uslan DZ, Khan AH, et al. Management and Outcome of Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infections. J Am Coll Cardiol. 2007;49:1851-9. doi:10.1016/j.jacc.2007.01.072.

232

Hussein AA, Baghdy Y, Wazni OM, et al. Microbiology of Cardiac Implantable Electronic Device Infections. JACC Clin Electrophysiol. 2016;2:498-505. doi:10.1016/j.jacep.2016.01.019.

233

Tarakji KG, Chan EJ, Cantillon DJ, et al. Cardiac implantable electronic device infections: Presentation, management, and patient outcomes. Hear Rhythm. 2010;7:1043-7. doi:10.1016/j.hrthm.2010.05.016.

234

Bongiorni MG, Di Cori A, Soldati E, et al. Intracardiac Echocardiography in Patients with Pacing and Defibrillating Leads: A Feasibility Study. Echocardiography. 2008;25:632-8. doi:10.1111/j.1540-8175.2008.00656.x.

235

Narducci ML, Pelargonio G, Russo E, et al. Usefulness of Intracardiac Echocardiography for the Diagnosis of Cardiovascular Implantable Electronic Device–Related Endocarditis. J Am Coll Cardiol. 2013;61:1398-405. doi:10.1016/j.jacc.2012.12.041.

236

Dalal A, Asirvatham SJ, Chandrasekaran K, et al. Intracardiac echocardiography in the detection of pacemaker lead endocarditis. J Am Soc Echocardiogr. 2002;15:1027-8. doi:10.1067/mje.2002.121276.

237

Sohail MR, Uslan DZ, Khan AH, et al. Infective Endocarditis Complicating Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infection. Mayo Clin Proc 2008;83:46-53. doi:10.4065/83.1.46.

238

Klug D, Lacroix D, Savoye C, et al. Systemic Infection Related to Endocarditis on Pacemaker Leads. Circulation. 1997;95:2098-107. doi:10.1161/01.CIR.95.8.2098.

239

Rundström H, Kennergren C, Andersson R, et al. Pacemaker Endocarditis During 18 Years in Göteborg. Scand J Infect Dis. 2004;36:674-9. doi:10.1080/00365540410022611.

240

Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular Cardiovascular Device–Related Infections. Circulation. 2003;108:2015-31. doi:10.1161/01.CIR.0000093201.57771.47.

241

Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management. Hear Rhythm. 2009;6:1085-104. doi:10.1016/j.hrthm.2009.05.020.

242

Pichlmaier M, Knigina L, Kutschka I, et al. Complete removal as a routine treatment for any cardiovascular implantable electronic device-associated infection. J Thorac Cardiovasc Surg. 2011;142:1482-90. doi:10.1016/j.jtcvs.2010.11.059.

243

Sohail MR, Uslan DZ, Khan AH, et al. Risk Factor Analysis of Permanent Pacemaker Infection. Clin Infect Dis. 2007;45:166-73. doi:10.1086/518889.

244

Meier-Ewert HK, Gray M-E, John RM. Endocardial pacemaker or defibrillator leads with infected vegetations: a single-center experience and consequences of transvenous extraction. Am Heart J. 2003;146:339-44. doi:10.1016/S0002-8703(03)00188-1.

245

del Río A, Anguera I, Miró JM, et al. Surgical Treatment of Pacemaker and Defibrillator Lead Endocarditis. Chest. 2003;124:1451-9. doi:10.1378/chest.124.4.1451.

246

Klug D, Balde M, Pavin D, et al. Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators. Circulation. 2007;116:1349-55. doi:10.1161/CIRCULATIONAHA.106.678664.

247

Deharo JC, Bongiorni MG, Rozkovec A, et al. "Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper" Europace. 2012;14:460. doi:10.1093/europace/eus035.

248

Grammes JA, Schulze CM, Al-Bataineh M, et al. Percutaneous Pacemaker and Implantable Cardioverter-Defibrillator Lead Extraction in 100 Patients With Intracardiac Vegetations Defined by Transesophageal Echocardiogram. J Am Coll Cardiol. 2010;55:886-94. doi:10.1016/j.jacc.2009.11.034.

249

Braun MU, Rauwolf T, Bock M, et al. Percutaneous Lead Implantation Connected to an External Device in Stimulation-Dependent Patients with Systemic Infection — A Prospective and Controlled Study. Pacing Clin Electrophysiol. 2006;29:875-9. doi:10.1111/j.1540-8159.2006.00454.x.

250

Kornberger A, Schmid E, Kalender G, et al. Bridge to Recovery or Permanent System Implantation: An Eight-Year Single-Center Experience in Transvenous Semipermanent Pacing. Pacing Clin Electrophysiol. 2013;36:1096-103. doi:10.1111/pace.12175.

251

Kawata H, Pretorius V, Phan H, et al. Utility and safety of temporary pacing using active fixation leads and externalized re-usable permanent pacemakers after lead extraction. Europace. 2013;15:1287-91. doi:10.1093/europace/eut045.

252

Pecha S, Aydin MA, Yildirim Y, et al. Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency. Europace. 2013;15:1205-9. doi:10.1093/europace/eut031.

253

Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic Prophylaxis for Permanent Pacemaker Implantation. Circulation. 1998;97:1796-801. doi:10.1161/01.CIR.97.18.1796.

254

Bertaglia E, Zerbo F, Zardo S, et al. Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: Incidence of long-term infective complications. PACE — Pacing Clin Electrophysiol. 2006;29:29-33. doi:10.1111/j.1540-8159.2006.00294.x.

255

Chiang KH, Chao TF, Lee WS, et al. How long should prophylactic antibiotics be prescribed for permanent pacemaker implantations? one day versus three days. Acta Cardiol Sin. 2013;29:341-6.

256

Wellens F, Pirlet M, Larbuisson R, et al. Prophylaxis in cardiac surgery. A controlled randomized comparison between cefazolin and cefuroxime. Eur J Cardiothorac Surg. 1995;9:325-9. doi:10.1016/S1010-7940(05)80191-5.

257

Ackah JK, Neal L, Marshall NR, et al. Antimicrobial prophylaxis in adult cardiac surgery in the United Kingdom and Republic of Ireland. J Infect Prev. 2021;22:83-90. doi:10.1177/1757177420971850.

258

Mirabel M, Sonneville R, Hajage D, et al. Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis. Eur Heart J. 2014;35:1195-204. doi:10.1093/eurheartj/eht303.

259

Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med. 2013;39:165-228. doi:10.1007/s00134-012-2769-8.

260

Lee M-R, Chang S-A, Choi S-H, et al. Clinical Features of Right-Sided Infective Endocarditis Occurring in Non-Drug Users. J Korean Med Sci. 2014;29:776. doi:10.3346/jkms.2014.29.6.776.

261

Stavi V, Brandstaetter E, Sagy I, et al. Comparison of Clinical Characteristics and Prognosis in Patients with Right- and Left-sided Infective Endocarditis. Rambam Maimonides Med J. 2019;10:e0003. doi:10.5041/RMMJ.10338.

262

Asgeirsson H, Thalme A, Weiland O. Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs. Medicine (Baltimore). 2016;95:e5617. doi:10.1097/MD.0000000000005617.

263

Carozza A, De Santo LS, Romano G, et al. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis. 2006;15:125-31.

264

Wilson LE, Thomas DL, Astemborski J, et al. Prospective Study of Infective Endocarditis among Injection Drug Users. J Infect Dis. 2002;185:1761-6. doi:10.1086/340827.

265

Martín-Dávila P, Navas E, Fortún J, et al. Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation size. Am Heart J. 2005;150:1099-106. doi:10.1016/j.ahj.2005.02.009.

266

Hussain ST, Witten J, Shrestha NK, et al. Tricuspid valve endocarditis. Ann Cardiothorac Surg. 2017;6:255-61. doi:10.21037/acs.2017.03.09.

267

Pulvirenti JJ, Kerns E, Benson C, et al. Infective endocarditis in injection drug users: Importance of human immunodeficiency virus serostatus and degree of immunosuppression. Clin Infect Dis. 1996;22:40-5. doi:10.1093/clinids/22.1.40.

268

Sousa C, Botelho C, Rodrigues D, et al. Infective endocarditis in intravenous drug abusers: an update. Eur J Clin Microbiol Infect Dis. 2012;31:2905-10. doi:10.1007/s10096-012-1675-x.

269

Lodise TP, McKinnon PS, Levine DP, Rybak MJ. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillinsusceptible Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51:3731-3. doi:10.1128/AAC.00101-07.

270

Torres-Tortosa M, de Cueto M, Vergara A, et al. Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Eur J Clin Microbiol Infect Dis. 1994;13:559-64. doi:10.1007/BF01971306.

271

Yung D, Kottachchi D, Neupane B, et al. Antimicrobials for right-sided endocarditis in intravenous drug users: A systematic review. J Antimicrob Chemother. 2007;60:921-8. doi:10.1093/jac/dkm324.

272

Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med. 1992;117:560-6. doi:10.7326/0003-4819-117-7-560.

273

Fortun J, Perez-Molina JA, Anon MT, et al. Right-sided endocarditis caused by Staphylococcus aureus in drug abusers. Antimicrob Agents Chemother. 1995;39:525-8. doi:10.1128/aac.39.2.525.

274

Martí-Carvajal AJ, Dayer M, Conterno LO, et al. A comparison of different antibiotic regimens for the treatment of infective endocarditis. Cochrane Database Syst Rev. 2020;2020. doi:10.1002/14651858.CD009880.pub3.

275

Al-Omari A, Cameron DW, Lee C, Corrales-Medina VF. Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review. BMC Infect Dis. 2014;14:140. doi:10.1186/1471-2334-14-140.

276

Murashita T. Surgical Treatment for Tricuspid Valve Infective Endocarditis. Adv. Concepts Endocarditis, InTech; 2018. doi:10.5772/intechopen.74951.

277

Niwa K. Infective endocarditis in congenital heart disease: Japanese national collaboration study. Heart. 2005;91:795-800. doi:10.1136/hrt.2004.043323.

278

Kuijpers JM, Koolbergen DR, Groenink M, et al. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: Focus on the use of prosthetic material. Eur Heart J. 2017;38:2048-56. doi:10.1093/eurheartj/ehw591.

279

Murakami T, Niwa K, Yoshinaga M, Nakazawa M. Factors associated with surgery for active endocarditis in congenital heart disease. Int J Cardiol. 2012;157:59-62. doi:10.1016/j.ijcard.2010.11.016.

280

San Román JA, López J, Vilacosta I, et al. Prognostic Stratification of Patients with Left-Sided Endocarditis Determined at Admission. Am J Med. 2007;120:369.e1-369.e7. doi:10.1016/j.amjmed.2006.05.071.

281

Moore B, Cao J, Kotchetkova I, Celermajer DS. Incidence, predictors and outcomes of infective endocarditis in a contemporary adult congenital heart disease population. Int J Cardiol. 2017;249:161-5. doi:10.1016/j.ijcard.2017.08.035.

282

Moons P. What do adult patients with congenital heart disease know about their disease, treatment, and prevention of complications? A call for structured patient education. Heart. 2001;86:74-80. doi:10.1136/heart.86.1.74.

283

Foley M. Cardiac disease. In: Dildy G, Belfort M, Saade G, et al. Critical care obstetrics, 5th ed. Oxford: Blackwell; 2004, p.256-283. ISBN: 978-1-4051-5273-0.

284

Montoya ME, Karnath BM, Ahmad M. Endocarditis during Pregnancy. South Med J. 2003;96:1156-7. doi:10.1097/01.SMJ.0000054503.18393.1E.

285

Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial endocarditis. J Endod. 1991;17:169-73. doi:10.1016/S0099-2399(06)82011-X.

286

Roos-Hesselink JW, Ruys TPE, Stein JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34:657-65. doi:10.1093/eurheartj/ehs270.

287

Morissens M, Viart P, Tecco L, et al. Does congenital heart disease severely jeopardise family life and pregnancies? Obstetrical history of women with congenital heart disease in a single tertiary centre. Cardiol Young. 2013:41-6.

288

Mazibuko B, Ramnarain H, Moodley J. An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South Africa. Cardiovasc J Afr. 2012;23:216-21. doi:10.5830/CVJA-2012-022.

289

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Kardiol Pol. 2019;77:245-326. doi:10.5603/KP.2019.0049.

290

Raymond M, Countouris M, Marino A, Berlacher KL. Infective endocarditis in pregnancy a contemporary cohort. J Am Coll Cardiol. 2020;75:2145. doi:10.1016/s0735-1097(20)32772-8.

291

Stucki G, Stier-Jarmer M, Grill E, Melvin J. Rationale and principles of early rehabilitation care after an acute injury or illness. Disabil Rehabil. 2005;27:353-9. doi:10.1080/09638280400014105.

292

Приказ Министерства здравоохранения РФ от 29 декабря 2012 г. N 1705н. "О порядке организации медицинской реабилитации".

Order of the Ministry of Health of the Russian Federation of December 29, 2012 N 1705n. On the organization of medical rehabilitation.(In Russ.)

293

Rasmussen T. Health, recovery and rehabilitation after infective endocarditis. Thesis for: PhD in Health and Medical Sciences. 2015. p. 74. doi:10.13140/RG.2.2.20263.75687.

294

Rasmussen TB, Zwisler AD, Sibilitz KL, et al. A randomised clinical trial of comprehensive cardiac rehabilitation versus usual care for patients treated for infective endocarditis-the CopenHeart IE trial protocol. BMJ Open. 2012;2:1929. doi:10.1136/bmjopen-2012-001929.

295

Gomes Neto M, Martinez BP, Reis HF, Carvalho VO. Pre- and postoperative inspiratory muscle training in patients undergoing cardiac surgery: systematic review and metaanalysis. Clin Rehabil. 2017;31:454-64. doi:10.1177/0269215516648754.

296

Waite I, Deshpande R, Baghai M, et al. Home-based preoperative rehabilitation (prehab) to improve physical function and reduce hospital length of stay for frail patients undergoing coronary artery bypass graft and valve surgery. J Cardiothorac Surg. 2017;12:91. doi:10.1186/s13019-017-0655-8.

297

Marmelo F, Rocha V, Moreira-Gonçalves D. The impact of prehabilitation on postsurgical complications in patients undergoing non-urgent cardiovascular surgical intervention: Systematic review and meta-analysis. Eur J Prev Cardiol. 2018;25:404-17. doi:10.1177/2047487317752373.

298

Brown JP, Clark AM, Dalal H, et al. Effect of patient education in the management of coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol 2013;20:701-14. doi:10.1177/2047487312449308.

299

Viswanathan M, Golin CE, Jones CD, et al. Interventions to Improve Adherence to Selfadministered Medications for Chronic Diseases in the United States. Ann Intern Med. 2012;157:785. doi:10.7326/0003-4819-157-11-201212040-00538.

300

Sanz M, Ceriello A, Buysschaert M, et al. Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International diabetes Federation and the European Federation of Periodontology. Diabetes Res Clin Pract. 2018;137:231-41. doi:10.1016/j.diabres.2017.12.001.

301

Knoll B, Tleyjeh IM, Steckelberg JM, et al. Infective Endocarditis Due to Penicillin-Resistant Viridans Group Streptococci. Clin Infect Dis. 2007;44:1585-92. doi:10.1086/518174.

302

Corra U, Piepoli MF, Carre F, et al. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: Key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitat. Eur Heart J. 2010;31:1967-74. doi:10.1093/eurheartj/ehq236.

303

Squires RW, Kaminsky LA, Porcari JP, et al. Progression of Exercise Training in Early Outpatient Cardiac Rehabilitation. J Cardiopulm Rehabil Prev. 2018;38:139-46. doi:10.1097/HCR.0000000000000337.

304

Mora S, Cook N, Buring JE, et al. Physical Activity and Reduced Risk of Cardiovascular Events. Circulation. 2007;116:2110-8. doi:10.1161/CIRCULATIONAHA.107.729939.

305

Fletcher GF, Ades PA, Kligfield P, et al. Exercise Standards for Testing and Training. Circulation. 2013;128:873-934. doi:10.1161/CIR.0b013e31829b5b44.

306

Samuelson G. Global strategy on diet, physical activity and health. Scand J Nutr. 2004;48:57. doi:10.1080/11026480410034349.

307

Lockhart PB, Brennan MT, Sasser HC, et al. Bacteremia Associated With Toothbrushing and Dental Extraction. Circulation. 2008;117:3118-25. doi:10.1161/CIRCULATIONAHA.107.758524.

308

Glenny A-M, Oliver R, Roberts GJ, et al. Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev. 2013;2013:CD003813. doi:10.1002/14651858.CD003813.pub4.

309

van der Meer JTM, Michel MF, Valkenburg HA, et al. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet. 1992;339:135-9. doi:10.1016/0140-6736(92)90207-J.

310

Lacassin F, Hoen B, Leport C, et al. Procedures associated with infective endocarditis in adults. Eur Heart J. 1995;16:1968-74. doi:10.1093/oxfordjournals.eurheartj.a060855.

311

Isaacs D. Antibiotic prophylaxis for infective endocarditis: A systematic review and metaanalysis. J Paediatr Child Health. 2017;53(9):921-2. doi:10.1111/jpc.13684.

312

Cahill TJ, Harrison JL, Jewell P, et al. Antibiotic prophylaxis for infective endocarditis: A systematic review and meta-Analysis. Heart. 2017;103(12):937-44. doi:10.1136/heartjnl-2015-309102.

313

Brignardello-Petersen R. Antibiotic prophylaxis probably reduces the risk of developing bacteremia in patients at risk of developing infective endocarditis who are undergoing dental extractions. J Am Dent Assoc. 2017;148:e169. doi:10.1016/j.adaj.2017.08.005.

314

Yu CHY, Minnema BJ, Gold WL. Bacterial infections complicating tongue piercing. Can J Infect Dis Med Microbiol. 2010;21:e70-e74. doi:10.1155/2010/987059.

315

Benito N. Health Care–Associated Native Valve Endocarditis: Importance of Nonnosocomial Acquisition. Ann Intern Med. 2009;150:586. doi:10.7326/0003-4819-150-9-200905050-00004.

316

Fernández‐Hidalgo N, Almirante B, Tornos P, et al. Contemporary Epidemiology and Prognosis of Health Care–Associated Infective Endocarditis. Clin Infect Dis. 2008;47:1287- 97. doi:10.1086/592576.

317

Selton-Suty C, Célard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey. Clin Infect Dis. 2012;54:1230-9. doi:10.1093/cid/cis199.

318

González Quintela A, Candela MJ, Vidal C, et al. Non-bacterial thrombotic endocarditis in cancer patients. Acta Cardiol. 1991;46:1-9.

319

Dutta T, Karas MG, Segal AZ, Kizer JR. Yield of Transesophageal Echocardiography for Nonbacterial Thrombotic Endocarditis and Other Cardiac Sources of Embolism in Cancer Patients With Cerebral Ischemia. Am J Cardiol. 2006;97:894-8. doi:10.1016/j.amjcard.2005.09.140.

320

Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384;1878-88. doi:10.1016/S0140-6736(14)60128-8.

321

Busca-Arenzana C, Robles-Marhuenda A, Ramos-Ruperto L, Alvarez-Troncoso J. Nonbacterial Thrombotic Endocarditis. In: Infective Endocarditis Edited by Peter Magnusson and Robin Razmi. IntechOpen; 2019, p. 291-4. ISBN: 978-1-78984-012-4. doi:10.5772/intechopen.84398.

322

Kebar YM, Avesta L, Habibzadeh A, Hemmati M. Libman-Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome. Casp J Intern Med. 2019;10:339-42. doi:10.22088/cjim.10.3.339.

323

Bell WR, Starksen NF, Tong S, Porterfield JK. Trousseau’s syndrome. Devastating coagulopathy in the absence of heparin. Am J Med. 1985;79:423-30. doi:10.1016/0002-9343(85)90028-2.

324

Mantovani F, Navazio A, Barbieri A, Boriani G. A first described case of cancer-associated non-bacterial thrombotic endocarditis in the era of direct oral anticoagulants. Thromb Res. 2017;149:45-7. doi:10.1016/j.thromres.2016.11.016.

325

Ferrari A, Botrugno I, Bombelli E, et al. Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned. Case report. World J Surg Oncol. 2008;6:49. doi:10.1186/1477-7819-6-49.

326

Mezzani A, Hamm LF, Jones AM, et al. Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation. Eur J Prev Cardiol. 2013;20:442-67. doi:10.1177/2047487312460484.

327

Global recommendations on physical activity for health. Geneva: WHO. 2010. p. 58. ISBN: 9789241599979.

328

Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:1694-740. doi:10.1161/HC3901.095960.

329

Hansen D, Dendale P, Coninx K, et al. The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology. Eur J Prev Cardiol. 2017;24:1017-31. doi:10.1177/2047487317702042.

330

Karvonen MJ, Kentala E, Mustala O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn. 1957;35:307-15.

331

Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Undefined. 2011;43:1575-81. doi:10.1249/MSS.0B013E31821ECE12.

332

Kaminsky LA, Brubaker PH, Guazzi M, et al. Assessing Physical Activity as a Core Component in Cardiac Rehabilitation: A position statement of the american association of cardiovascular and pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2016;36:217-26. doi:10.1097/HCR.0000000000000191.

333

Nicolau DP, Freeman CD, Belliveau PP, et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995;39:650- 5. doi:10.1128/AAC.39.3.650.

334

Dahl A, Rasmussen R V., Bundgaard H, et al. Enterococcus faecalis Infective Endocarditis. Circulation. 2013;127:1810-7. doi:10.1161/CIRCULATIONAHA.112.001170.

335

Olaison L, Schadewitz K. Enterococcal Endocarditis in Sweden, 1995-1999: Can Shorter Therapy with Aminoglycosides Be Used? Clin Infect Dis. 2002;34:159-66. doi:10.1086/338233.

336

Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement from the American Heart Association. Circulation. 2021;143:E963-78. doi:10.1161/CIR.0000000000000969.

The authors declare that there are no conflicts of interest present.